Metraipolis › archive › dc_fb4bf8e993ae

Unveiling the mechanism of calcitriol in treating type 2 diabetes mellitus: A combined network pharmacology and in vitro approach targeting ERS-related pathways — Europe PMC PMID:41990027

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41990027
DOI
10.1371/journal.pone.0347246
License (as archived)
solo-consultazione
Archived
2026-10-08T03:07:22.375Z
SHA-256 of the archived text
a2144a7ec8324e025f0b6632f532dcfba3a97c8a59083335687876c510a4ac04
Stable URL of this page
https://metraipolis.com/documento/dc_fb4bf8e993ae

How to cite

Unveiling the mechanism of calcitriol in treating type 2 diabetes mellitus: A combined network pharmacology and in vitro approach targeting ERS-related pathways — Europe PMC PMID:41990027 — Europe PMC (en), https://europepmc.org/article/MED/41990027 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb4bf8e993ae (Metraipolis archive dc_fb4bf8e993ae, sha256 a2144a7ec8324e025f0b6632f532dcfba3a97c8a59083335687876c510a4ac04)
BibTeX
@misc{dcfb4bf8e993ae,
  title = {Unveiling the mechanism of calcitriol in treating type 2 diabetes mellitus: A combined network pharmacology and in vitro approach targeting ERS-related pathways — Europe PMC PMID:41990027},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41990027},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb4bf8e993ae; sha256 a2144a7ec8324e025f0b6632f532dcfba3a97c8a59083335687876c510a4ac04},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41990027. Agents can read the archived copy with the MCP tool read_document.